How Label-Free Technologies Are Used in Drug Discovery
Many small molecule drugs and biologics interact with a therapeutic target to change its function. Hence, to accelerate drug discovery, streamlining affinity analysis workflows is essential.
The drug development process can be long, risky and costly. However, modern label-free technologies such as surface plasmon resonance (SPR) or bio-layer interferometry (BLI) can help researchers expedite their assay workflows. Such technologies support the fast and effective analyses of small molecule-protein interactions, meaning key workflow decisions become quicker and easier.
This eBook highlights how label-free technologies are used in a variety of biopharmaceutical applications, focusing on the latest solutions for robust discovery workflows.
Download this eBook to discover:
- The benefits of label-free approaches to target identification, selection and optimization
- High-throughput methods capable of analyzing novel, complex biologics
- Solutions to accelerate cell line development, affinity assays and kinetics characterization